SBP solbec pharmaceuticals limited

genentech has another big rise

  1. TDF
    102 Posts.
    I noticed that Genentech had another big rise this week, and has now doubled in price in the past 4 months. The market cap increase in 4 months has been a staggering $45 billion US.


    And little old Solbec has dropped by 40% in the same time frame to a mere $12m AUS.

    I still hold SBP. Still optimistic that its bad run will end.

    TDF
 
watchlist Created with Sketch. Add SBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.